Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Glycemic variability: too often overlooked in type 2 diabetes?

Johnson EL.

J Fam Pract. 2010 Aug;59(8):E1-8. Review.

PMID:
20714447
2.

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK.

Diabetes Care. 1998 Apr;21(4):574-9.

PMID:
9571345
3.

[Supplemental insulin therapy of type 2 diabetes follows the example of nature. Replace what the patient lacks].

[No authors listed]

MMW Fortschr Med. 2004 May 27;146(22):47. German. No abstract available.

PMID:
15373112
4.

Continuous glucose monitoring in youth with type 2 diabetes: overcoming barriers to successful treatment.

Boland EA, Tamborlane WV.

Diabetes Technol Ther. 2000;2 Suppl 1:S53-9. No abstract available.

PMID:
11469633
5.

Slow response to loss of glycemic control in type 2 diabetes mellitus.

Brown JB, Nichols GA.

Am J Manag Care. 2003 Mar;9(3):213-7.

6.

Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.

Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z; Romania/Russia Mix25 Study Group.

Clin Ther. 2001 Oct;23(10):1732-44.

PMID:
11726007
7.

Combined insulin and sulfonylurea therapy for type 2 diabetes mellitus.

Riddle MC.

Diabetes Res Clin Pract. 1991 Jan;11(1):3-8. Review. No abstract available.

PMID:
2019232
8.

Relationship between plasma Endothelin-1 and glycemic control in type 2 diabetes mellitus.

Sánchez SS, Aybar MJ, Velarde MS, Prado MM, Carrizo T.

Horm Metab Res. 2001 Dec;33(12):748-51. No abstract available.

PMID:
11753762
9.

[New fast-acting insulin analog. This insulin profits type l and type 2 diabetics].

Wepner U.

MMW Fortschr Med. 2004 Nov 18;146(47):62-3. German. No abstract available.

PMID:
15624662
10.

Diabetes. Paradoxical effects of tightly controlled blood sugar.

Taubes G.

Science. 2008 Oct 17;322(5900):365-7. doi: 10.1126/science.322.5900.365. No abstract available.

PMID:
18927369
11.

[Intensive glucose control in type 2 diabetes. The benefit greater than the risks?].

Rydén M, Freyschuss B.

Lakartidningen. 2008 Oct 15-21;105(42):2910-1. Swedish. No abstract available.

PMID:
19025147
12.

[American Diabetes Association's Annual Meeting: new data on insulin glargine: early combination promises more success].

[No authors listed]

MMW Fortschr Med. 2005 Aug 18;147(33-34):44-5. German. No abstract available.

PMID:
16138636
13.

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.

Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB.

Diabetes Care. 2001 Apr;24(4):631-6.

PMID:
11315821
15.

Changes in depressive symptoms and glycemic control in diabetes mellitus.

Georgiades A, Zucker N, Friedman KE, Mosunic CJ, Applegate K, Lane JD, Feinglos MN, Surwit RS.

Psychosom Med. 2007 Apr;69(3):235-41. Epub 2007 Apr 9.

PMID:
17420441
16.

[Insulin detemir compared with NPH insulin. No significant differences identified in the studies].

Liedholm H, Linné AB.

Lakartidningen. 2006 May 3-9;103(18):1417, 1419-22, 1424-6. Review. Swedish. No abstract available.

PMID:
16729454
17.

Postprandial hyperglycaemia--its importance and implications.

Lüddeke HJ.

Int J Clin Pract Suppl. 1999 Jul;104:3-7; discussion 18-20. Review. No abstract available.

PMID:
12669731
18.

Impact of comorbid conditions and race/ethnicity on glycemic control among the US population with type 2 diabetes, 1988-1994 to 1999-2004.

Suh DC, Choi IS, Plauschinat C, Kwon J, Baron M.

J Diabetes Complications. 2010 Nov-Dec;24(6):382-91. doi: 10.1016/j.jdiacomp.2009.07.001. Epub 2009 Aug 27.

PMID:
19716320
19.

Randomized study of two different target levels of glycemic control within the acceptable range in type 2 diabetes. Effects on well-being at 1 year.

van der Does FE, de Neeling JN, Snoek FJ, Grootenhuis PA, Kostense PJ, Bouter LM, Heine RJ.

Diabetes Care. 1998 Dec;21(12):2085-93.

PMID:
9839098
20.

Comparison of glycemic control of type 2 diabetes between private hospital and governmental hospital.

Al-Shaikh AA.

Saudi Med J. 2006 Mar;27(3):424-6. No abstract available.

PMID:
16532119

Supplemental Content

Support Center